ESR1 and cancer: As tamoxifen is the mostly prescribed agent for endocrine therapy, we will use tamoxifen as an example to illustrate the impact of endocrine therapy in inflammation/immune modulation in addition to its direct inhibition of ER-positive cancer cells.